D. Waugh

发表

Purification and characterization of urotensin II from the brain of a teleost (trout, Oncorhynchus mykiss) and an elasmobranch (skate, Raja rhina).

J. Conlon, D. Waugh, 1993, General and comparative endocrinology.

Urotensin II from the river lamprey (Lampetra fluviatilis), the sea lamprey (Petromyzon marinus), and the paddlefish (Polyodon spathula).

S. Sower, J. Conlon, J. Youson, 1995, General and comparative endocrinology.

Overexpression of the alpha1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy.

D. Morilak, S. Sands, M. Zuscik, 2000, Nature medicine.

Binding, partial agonism, and potentiation of alpha(1)-adrenergic receptor function by benzodiazepines: A potential site of allosteric modulation.

D. Perez, R. Gaivin, D. Damron, 1999, The Journal of pharmacology and experimental therapeutics.

Hypotension, Autonomic Failure, and Cardiac Hypertrophy in Transgenic Mice Overexpressing the α1B-Adrenergic Receptor*

M. Zuscik, M. Piascik, D. Perez, 2001, The Journal of Biological Chemistry.

Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates.

N. Hazon, J. Conlon, D. Waugh, 1996, The Journal of experimental zoology.

Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists.

M. Piascik, D. Perez, D. McCune, 2000, Molecular pharmacology.

Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss.

H. Vaudry, K. Olson, D. Conklin, 1996, The American journal of physiology.

Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors.

P. Abel, D. Smith, D. Waugh, 1999, The Journal of pharmacology and experimental therapeutics.

Growth inhibitory activity of extracted material and isolated compounds from the fruits of Kigelia pinnata.

Colin R. O'Dowd, C. Higgins, W. Watters, 2010, Planta medica.

Radioligand binding using 125I-labeled peptides.

W. B. Jeffries, P. Abel, D. Waugh, 1997, Methods in molecular biology.

Analysis of data from "cold saturation" radioligand binding experiments.

W. B. Jeffries, P. Abel, D. Waugh, 1997, Methods in molecular biology.

Novel Aromatic Residues in Transmembrane Domains IV and V Involved in Agonist Binding at α1a-Adrenergic Receptors*

M. Zuscik, D. Perez, D. Waugh, 2000, The Journal of Biological Chemistry.

A peptide from the caudal neurosecretory system of the dogfish Scyliorhinus canicula that is structurally related to urotensin I.

N. Hazon, J. Conlon, R. Balment, 1995, General and comparative endocrinology.

Primary structures and biological activities of substance-P-related peptides from the brain of the dogfish, Scyliorhinus canicula.

N. Hazon, J. Conlon, R. Balment, 1993, European journal of biochemistry.

Tachykinins with unusual structural features from a urodele, the amphiuma, an elasmobranch, the hammerhead shark, and an agnathan, the river lamprey

P. F. Nielsen, C. Bjenning, J. Conlon, 1995, Peptides.

Novel tachykinins from the brain of the sea lamprey, Petromyzon marinus, and the skate, Raja rhina

C. Bjenning, S. Sower, J. Conlon, 1994, Peptides.

Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophy

Scott Sands, D. Morilak, S. Sands, 2000, Nature Medicine.

Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists.

P. Gonzalez-Cabrera, M. Zuscik, D. Perez, 2001, The Journal of biological chemistry.

Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization

H. Vaudry, S. Lahrichi, M. Vallarino, 1996, The Journal of comparative neurology.

Phe-308 and Phe-312 in Transmembrane Domain 7 Are Major Sites of α1-Adrenergic Receptor Antagonist Binding

P. Gonzalez-Cabrera, M. Zuscik, D. Perez, 2001, The Journal of Biological Chemistry.

Synthesis and in vitro and in vivo evaluation of a series of dihydroisocoumarin derivatives conjugated with fatty acids, alcohols, and amines as potential anticancer agents.

P. Johnston, C. Higgins, Timothy J. Mills, 2009, Bioconjugate chemistry.

The agonism and synergistic potentiation of weak partial agonists by triethylamine in alpha 1-adrenergic receptor activation: evidence for a salt bridge as the initiating process.

M. Piascik, D. Perez, J. Porter, 1998, Molecular pharmacology.

Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity.

P. Abel, D. Smith, M. Hulce, 2003, Journal of medicinal chemistry.

Role of conformational constraints of position 7 of the disulphide bridge of h-alpha-CGRP derivatives in their agonist versus antagonist properties.

P. Abel, D. Smith, S. Saha, 2009, The journal of peptide research : official journal of the American Peptide Society.

Isolation, localization, and cardiovascular activity of tachykinins from the stomach of the bowfin Amia calva.

K. Olson, J. Conlon, J. Youson, 1995, The American journal of physiology.